Weng TY - Search Results

1

PODXL2 maintains cellular stemness and promotes breast cancer development through the Rac1/Akt pathway.

Lin YY, Wang CY, Phan NN, Chiao CC, Li CY, Sun Z, Hung JH, Chen YL, Yen MC, Weng TY, Hsu HP, Lai MD. Lin YY, et al. Among authors: weng ty. Int J Med Sci. 2020 Jun 29;17(11):1639-1651. doi: 10.7150/ijms.46125. eCollection 2020. Int J Med Sci. 2020. PMID: 32669966 Free PMC article.

2

A combination of the metabolic enzyme inhibitor APO866 and the immune adjuvant L-1-methyl tryptophan induces additive antitumor activity.

Yang HJ, Yen MC, Lin CC, Lin CM, Chen YL, Weng TY, Huang TT, Wu CL, Lai MD. Yang HJ, et al. Among authors: weng ty. Exp Biol Med (Maywood). 2010 Jul;235(7):869-76. doi: 10.1258/ebm.2010.010001. Exp Biol Med (Maywood). 2010. PMID: 20558841

3

Skin delivery of short hairpin RNA of indoleamine 2,3 dioxygenase induces antitumor immunity against orthotopic and metastatic liver cancer.

Huang TT, Yen MC, Lin CC, Weng TY, Chen YL, Lin CM, Lai MD. Huang TT, et al. Among authors: weng ty. Cancer Sci. 2011 Dec;102(12):2214-20. doi: 10.1111/j.1349-7006.2011.02094.x. Epub 2011 Oct 17. Cancer Sci. 2011. PMID: 21899659 Free article.

4

A novel cancer therapeutic using thrombospondin 1 in dendritic cells.

Weng TY, Huang SS, Yen MC, Lin CC, Chen YL, Lin CM, Chen WC, Wang CY, Chang JY, Lai MD. Weng TY, et al. Mol Ther. 2014 Feb;22(2):292-302. doi: 10.1038/mt.2013.236. Epub 2013 Oct 15. Mol Ther. 2014. PMID: 24127010 Free PMC article.

5

Suppression of mucin 2 promotes interleukin-6 secretion and tumor growth in an orthotopic immune-competent colon cancer animal model.

Shan YS, Hsu HP, Lai MD, Yen MC, Fang JH, Weng TY, Chen YL. Shan YS, et al. Among authors: weng ty. Oncol Rep. 2014 Dec;32(6):2335-42. doi: 10.3892/or.2014.3544. Epub 2014 Oct 13. Oncol Rep. 2014. PMID: 25322805 Free PMC article.

6

Argininosuccinate synthetase 1 suppression and arginine restriction inhibit cell migration in gastric cancer cell lines.

Shan YS, Hsu HP, Lai MD, Yen MC, Chen WC, Fang JH, Weng TY, Chen YL. Shan YS, et al. Among authors: weng ty. Sci Rep. 2015 Apr 30;5:9783. doi: 10.1038/srep09783. Sci Rep. 2015. PMID: 25928182 Free PMC article.

7

Therapeutics targeting CD90-integrin-AMPK-CD133 signal axis in liver cancer.

Chen WC, Chang YS, Hsu HP, Yen MC, Huang HL, Cho CY, Wang CY, Weng TY, Lai PT, Chen CS, Lin YJ, Lai MD. Chen WC, et al. Among authors: weng ty. Oncotarget. 2015 Dec 15;6(40):42923-37. doi: 10.18632/oncotarget.5976. Oncotarget. 2015. PMID: 26556861 Free PMC article.

8

Systematic Analysis of Gene Expression Alterations and Clinical Outcomes for Long-Chain Acyl-Coenzyme A Synthetase Family in Cancer.

Chen WC, Wang CY, Hung YH, Weng TY, Yen MC, Lai MD. Chen WC, et al. Among authors: weng ty. PLoS One. 2016 May 12;11(5):e0155660. doi: 10.1371/journal.pone.0155660. eCollection 2016. PLoS One. 2016. PMID: 27171439 Free PMC article.

9

Differential Expression Pattern of THBS1 and THBS2 in Lung Cancer: Clinical Outcome and a Systematic-Analysis of Microarray Databases.

Weng TY, Wang CY, Hung YH, Chen WC, Chen YL, Lai MD. Weng TY, et al. PLoS One. 2016 Aug 11;11(8):e0161007. doi: 10.1371/journal.pone.0161007. eCollection 2016. PLoS One. 2016. PMID: 27513329 Free PMC article.

10

Cancer stem cell marker CD90 inhibits ovarian cancer formation via β3 integrin.

Chen WC, Hsu HP, Li CY, Yang YJ, Hung YH, Cho CY, Wang CY, Weng TY, Lai MD. Chen WC, et al. Among authors: weng ty. Int J Oncol. 2016 Nov;49(5):1881-1889. doi: 10.3892/ijo.2016.3691. Epub 2016 Sep 15. Int J Oncol. 2016. PMID: 27633757 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Search Page

Filters